Damianov L, Novachkov V, Ivanov S
Akush Ginekol (Sofiia). 1997;36(1):32-3.
The author reveal the results of treatment with ciclopiroxolamine of women suffering from mycotic colpitis and using OC's. The research covers 26 women users of monophasic OC's with mycotic colpitis during the last 2-3 weeks before the research. The cause for the colpitis in 92% of cases is Candida albicans. The treatment was successful in 84.6% of the cases after the first 6-day-course with Batrafen creme. With 7.7% the treatment course with Batrafen creme was repeated, and with another 7.7% was included oral antimycotic (itraconazol). After treatment was performed microbiological check-up that confirmed the positive result of treatment. The authors' conclusion is that Batrafen creme is an effective device suitable for application on patients, CO's users.
作者揭示了患有霉菌性阴道炎且正在使用口服避孕药（OC）的女性使用环吡酮胺治疗的结果。该研究涵盖了26名在研究前最后2至3周患有霉菌性阴道炎的单相口服避孕药使用者。92%的病例中阴道炎的病因是白色念珠菌。在使用Batrafen乳膏进行首个6天疗程后，84.6%的病例治疗成功。7.7%的患者重复了Batrafen乳膏治疗疗程，另有7.7%的患者加用了口服抗真菌药（伊曲康唑）。治疗后进行了微生物学检查，证实了治疗的阳性结果。作者的结论是，Batrafen乳膏是一种适用于口服避孕药使用者的有效治疗手段。
